Corporate Breaking News
Corporate Breaking News
Home : Moberg Pharma: Interim report April - June 2020
Aug 11
2020

Moberg Pharma: Interim report April - June 2020

STOCKHOLM, Aug. 11, 2020 /PRNewswire/ -- The Primary endpoint was met in the Phase 3 study TWELVE MONTH PERIOD (JUL 2019-JUN 2020) Net revenue SEK 50.5 million (15.6) * EBITDA SEK 29.0 million (-3.0) * Operating profit (EBIT) SEK 26.4 million (-4.2) * Profit after tax SEK 20.0 million (-4....
Source:https://www.prnewswire.com:443/news-releases/moberg-pharma-interim-report-april---june-2020-301109659.html
 
Related News
» Veoneer completes divestiture of US brake control business
» Stonebranch gilt laut den Cybersicherheitsexperten von Secuvera als höchst sicher
Home
About us
Archive
Sitemap
Powered By Corporate Breaking News.com Home| About us| Archive News| Sitemap